Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Humes

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Kidney International|October 2, 2004
Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failureH David Humes, William F Weitzel, Robert H Bartlett, et al.
BMC Nephrology|July 3, 2021
Regional citrate anticoagulation "non-shock" protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearanceLenar Yessayan, Ryann Sohaney, Vidhit Puri, et al.
Journal of Tissue Engineering and Regenerative Medicine|November 19, 2016
Development of a wearable bioartificial kidney using the Bioartificial Renal Epithelial Cell System (BRECS)Kimberly A Johnston, Angela J Westover, Alvaro Rojas-Pena, et al.
Blood Purification|August 22, 2023
Hemolytic Uremic Syndrome-Induced Acute Kidney Injury Treated via Immunomodulation with the Selective Cytopheretic DeviceH Rhodes Hambrick, Kara Short, David Askenazi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2002
Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cellsH David Humes, William H Fissell, William F Weitzel, et al.
BMJ Open|November 13, 2015
Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort studyAlyshah Abdul Sultan, Joe West, Olof Stephansson, et al.
Journal of Medical Economics|August 23, 2025
Projected hospitalization cost impact of the selective cytopheretic device in pediatric acute kidney injuryH David Humes, Nathan Kleinman, Jennifer Kammerer, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2024
Systematic review: Mortality associated with raised faecal immunochemical test and positive faecal occult blood resultsFrancesca Ligori Malcolm, Anjali K D S Yapa, Zhen Yu Wong, et al.
Critical Care Explorations|October 23, 2023
Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ FailureH David Humes, Stuart L Goldstein, Lenar T Yessayan, et al.
Plos One|April 6, 2023
Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in humanH David Humes, Keith D Aaronson, Deborah A Buffington, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Kidney International|October 2, 2004
Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failureH David Humes, William F Weitzel, Robert H Bartlett, et al.
BMC Nephrology|July 3, 2021
Regional citrate anticoagulation "non-shock" protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearanceLenar Yessayan, Ryann Sohaney, Vidhit Puri, et al.
Journal of Tissue Engineering and Regenerative Medicine|November 19, 2016
Development of a wearable bioartificial kidney using the Bioartificial Renal Epithelial Cell System (BRECS)Kimberly A Johnston, Angela J Westover, Alvaro Rojas-Pena, et al.
Blood Purification|August 22, 2023
Hemolytic Uremic Syndrome-Induced Acute Kidney Injury Treated via Immunomodulation with the Selective Cytopheretic DeviceH Rhodes Hambrick, Kara Short, David Askenazi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2002
Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cellsH David Humes, William H Fissell, William F Weitzel, et al.
BMJ Open|November 13, 2015
Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort studyAlyshah Abdul Sultan, Joe West, Olof Stephansson, et al.
Journal of Medical Economics|August 23, 2025
Projected hospitalization cost impact of the selective cytopheretic device in pediatric acute kidney injuryH David Humes, Nathan Kleinman, Jennifer Kammerer, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2024
Systematic review: Mortality associated with raised faecal immunochemical test and positive faecal occult blood resultsFrancesca Ligori Malcolm, Anjali K D S Yapa, Zhen Yu Wong, et al.
Critical Care Explorations|October 23, 2023
Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ FailureH David Humes, Stuart L Goldstein, Lenar T Yessayan, et al.
Plos One|April 6, 2023
Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in humanH David Humes, Keith D Aaronson, Deborah A Buffington, et al.
Pageof 11